Quantcast

Posts related to ‘BIIB’

biotech

The Next Blockbuster Drugs: A $170 Billion Opportunity

Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line data, a new biotech-based treatment, and a massive potential ...
Read Full Story »

Biotech Business Daily (BIIB, VRTX, ALNY, STEM)

Here are some of the top stories affecting key drug and biotech stocks this Friday.  We also have links through to more detailed coverage and analysis at BioHealthInvestor.com: Biogen Idec ...
Read Full Story »

Biotech Business Daily (RIGL, BIIB, ARRY, ALNY, FOLD, HALO, AOB, STEM)

Here are some of the top stories affecting key drug and biotech stocks that have links through to more in-depth coverage and analysis today at the website BioHealthInvestor.com: Rigel Pharmaceuticals ...
Read Full Story »
newspaper

Media Digest 8/30/2009 Reuters, WSJ, NYTimes, FT, Bloomberg

Reuters:   Cybercrime is spreading fast on Facebook. Reuters:   GM will seek to sell most of its assets to a new company. Reuters:    Madoff got 150 years in prison. Reuters:   AIG (AIG) ...
Read Full Story »
newspaper

Media Digest 6/10/2009 Reuters, WSJ, NYTimes, FT, Bloomberg

Reuters: The Supreme Court delays  Chrysler deal. Reuters:   The cleared ten banks to repay TARP include JPMorgan (JPM), Goldmand Sachs (GS), American Express (AXP), Cpaital One(COF), State Street (STT), BBT ...
Read Full Story »
newspaper

Media Digest 6/5/2009 Reuters, WSJ, NYTimes, FT, Bloomberg

Reuters:   Rio Tinto (RTP) has killed a deal with Chinalco for one with BHP (BHP). Reuters:   US regulators insisted JP Morgan (JPM) and Amex (AXP) raise money to exit the ...
Read Full Story »

Weekend of Cancer Data at AACR Ahead of ASCO (ALTH, AMGN, ARIA, ARRY, AZN, BIIB, CELG, CRIS, IMMU, IMGN, INFI, MEDX, MNTA, ONCY, PFE, PCYC, SUPG, TELK, THLD)

This weekend will be a potentially important oncology and cancer news weekend for drug and biotech stocks.  The American Association for Cancer Research Meeting will actually have a 100th annual ...
Read Full Story »
burning-money-pic42

MS Setback for Acorda (ACOR, BIIB)

Acorda Therapeutics, Inc. (NASDAQ: ACOR) is taking it right on the chin this morning.  The company announced that it has received a "refuse to file letter" from the FDA regarding ...
Read Full Story »

Carl Icahn Holdings Show No Immunity To Market (IEP, BIIB, AMLN, MOT, YHOO, WMB, APC, TWX, TWC, AMD, TELK, QRCP, LEA, TIN, JCP)

Billionaire and activist investor Carl Icahn has made some  large changes to his portfolio holdings.  He and Icahn Capital, L.P. have not been immune to the market sell-off as you ...
Read Full Story »
Biogen_logo

Carl Icahn Goes After Biogen Idec (BIIB)

Biogen Idec (NASDAQ: BIIB) is coming under fire from activist investor Carl Icahn this morning.  A release came out as a "shareholder proposal" from Icahn Partners LP.  He is asking ...
Read Full Story »
Biogen_logo

Can Biogen Idec Earnings Generate A Buyout? (BIIB, AMGN, GILD, GENZ, CELG, MRK, SNY, GSK)

Biogen Idec Inc. (NASDAQ: BIIB) is set to report earnings on Friday morning.  What many investors probably want to know is if these results -- or more importantly its guidance ...
Read Full Story »
Burning_money_pic

Top Pre-Market Analyst Downgrades (AMLN, BIIB, CIEN, XOM, GFA, MXIM, BTU, SLT, SPWRA)

These are some of the top pre-market downgrades and cautious calls we have seen from Wall Street analysts this Wednesday morning:Amylin Pharmaceuticals (AMLN) Cut to Sell at Canaccord Adams.Biogen Idec ...
Read Full Story »
Money_stack_pic

Top Pre-Market Analyst Upgrades (ARMH, BIIB, CAT, CVH, HCBK, LEN, MOH, TTEK)

These are some of the top analyst upgrades and positive research calls we have seen from Wall Street analysts with more than two hours until the market opens this Tuesday ...
Read Full Story »
Money_stack_pic_2

Top 10 Pre-Market Analyst Upgrades & Downgrades (ALTR, AMZN, BCE, BIIB, LEAP, PDLI, CLUB, VAR, AUY)

It is still fairly thin in analyst upgrades and downgrades as this week marks the return of investment banking and research departments from what is nearly a two-week hiatus.  Here ...
Read Full Story »
Money_stack_pic

Is Pfizer About To Be On Acquisition Path? (PFE, AMGN, WYE, GILD, BMY, LLY, SGP, CELG, GENZ, BIIB)

There may be some speculation that drug giant Pfizer Inc. (NYSE: PFE) is looking at expansion through acquisitions.  The FT reported that the world's largest pharmaceutical company is willing to ...
Read Full Story »